Merck MRK and Japan’s Daiichi Sankyo announced the dosing of the first patient in the phase III IDeate-Esophageal01 study evaluating their B7-H3 directed DXd antibody-drug conjugate (ADC ...

“This year’s ASCO marks the fourth in a row where potential practice-changing ENHERTU data will be showcased,” said Ken Takeshita, MD, Global Head, R&D, Daiichi Sankyo. “With the results ...

AZ, Daiichi's Enhertu nabs 7th FDA nod, including in 'HER2-ultralow' use, in breast cancer first In the trial, the Enhertu group showed an improved safety profile versus SOC.

IHH Healthcare, supported by Mitsui, has increased its compensation claim against Daiichi Sankyo to $1.3 billion in the Tokyo District Court, related to the Fortis Healthcare acquisition.

In addition, AstraZeneca, Daiichi Sankyo, and the pan-Canadian Pharmaceutical Alliance (pCPA) have signed a Letter of Intent under the Temporary Access Process (pTAP). Together with the TLR ...

Daiichi Kigenso Kagaku-Kogyo Co. Ltd. (4082.TO) Japan Year Ended March 31 GROUP 2025 2024 Revenue Y33.64 bln Y35.22 bln Operating Profit Y2.28 bln Y2.42 bln Pretax Profit Y632.00 mln Y2.94 bln Net ...

WHILE DRIVING TO THE TERMINAL, THE AIRPORT IS UNVEILING THIS NEW LOGO, WHICH WILL BE SHOWN ON THE NORTH SIDE OF ITS BRAND NEW PARKING GARAGE. THE GARAGE WILL ADD 1100 NEW ON SITE PARKING SPACES.

IHH Healthcare said on Tuesday its unit has filed a petition in a Tokyo court to revise damages sought from Japan's Daiichi Sankyo over its Fortis Healthcare stake buy to up to 109.3 billion rupees ...

Natalia included her late father's iconic Nike sheath logo at the top, hovering right on her heart. Natalia graduated from USC's School of Cinematic Arts. Congratulations poured in from USC women ...

Lifehacker has been a go-to source of tech help and life advice since 2005. Our mission is to offer reliable tech help and credible, practical, science-based life advice to help you live better ...

The new hue helps to create a more cohesive brand. Nobody is quite sure exactly when the logo changed, however one blogger wrote in March 2025 that the logo was still grey and black. However ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...